Profiling analysis of long non-coding RNA and mRNA in parathyroid carcinoma.
暂无分享,去创建一个
Yupei Zhao | Q. Liao | M. Cui | Ronghua Zhang | Xiang Gao | Z. Su | Ya Hu | Mengyi Wang | Peipei Wang | Xiang Zhang
[1] Kotb Abdelmohsen,et al. Cytoplasmic functions of long noncoding RNAs , 2018, Wiley interdisciplinary reviews. RNA.
[2] D. Corcoran,et al. Transcriptional profiling reveals distinct classes of parathyroid tumors in PHPT. , 2018, Endocrine-related cancer.
[3] C. Klinge. Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers. , 2018, Endocrine-related cancer.
[4] Ming Cui,et al. Verification of candidate microRNA markers for parathyroid carcinoma , 2018, Endocrine.
[5] Kaijuan Wang,et al. Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population. , 2018, Gene.
[6] A. Alzahrani,et al. Long noncoding RNAs: emerging players in thyroid cancer pathogenesis. , 2018, Endocrine-related cancer.
[7] A. Chou,et al. Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features , 2018, The American journal of surgical pathology.
[8] Yun Zhang,et al. Prognostic value of long non-coding RNA PVT1 as a novel biomarker in various cancers: a meta-analysis , 2017, Oncotarget.
[9] R. Thakker,et al. Molecular genetics of syndromic and non‐syndromic forms of parathyroid carcinoma , 2017, Human mutation.
[10] Xin Liu,et al. Plasma lncRNA GAS8-AS1 as a Potential Biomarker of Papillary Thyroid Carcinoma in Chinese Patients , 2017, International journal of endocrinology.
[11] R. Lloyd,et al. WHO classification of tumours of endocrine organs , 2017 .
[12] L. Muscarella,et al. Alterations of DNA methylation in parathyroid tumors , 2017, Molecular and Cellular Endocrinology.
[13] G. Akpinar,et al. Proteomics Analysis of Tissue Samples Reveals Changes in Mitochondrial Protein Levels in Parathyroid Hyperplasia over Adenoma. , 2017, Cancer genomics & proteomics.
[14] N. Perrier,et al. Epigenetic processes in sporadic parathyroid neoplasms , 2017, Molecular and Cellular Endocrinology.
[15] E. Schadt,et al. Genomic profiling reveals mutational landscape in parathyroid carcinomas. , 2017, JCI insight.
[16] S. Corbetta,et al. Epigenetic Alterations in Parathyroid Cancers , 2017, International journal of molecular sciences.
[17] S. Xue,et al. Preoperative diagnosis and prognosis in 40 Parathyroid Carcinoma Patients , 2016, Clinical endocrinology.
[18] M. Dinger,et al. Long noncoding RNAs in cancer: mechanisms of action and technological advancements , 2016, Molecular Cancer.
[19] Xiang Du,et al. Circulating long non-coding RNAs in cancer: current status and future perspectives , 2016, Molecular Cancer.
[20] G. Westin. Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours , 2016, Journal of internal medicine.
[21] Howard Y. Chang,et al. Long Noncoding RNAs in Cancer Pathways. , 2016, Cancer cell.
[22] M. Dinger,et al. Endogenous microRNA sponges: evidence and controversy , 2016, Nature Reviews Genetics.
[23] L. You,et al. Long non-coding RNA PVT1 and cancer. , 2016, Biochemical and biophysical research communications.
[24] Ming Sun,et al. Long Noncoding RNA PVT1 Promotes Non–Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression , 2016, Molecular Cancer Therapeutics.
[25] H. Lodish,et al. Long non-coding RNAs as regulators of the endocrine system , 2015, Nature Reviews Endocrinology.
[26] D. Largaespada,et al. PVT1 dependence in cancer with MYC copy-number increase , 2014, Nature.
[27] A. Arnold,et al. Genetic and epigenetic changes in sporadic endocrine tumors: Parathyroid tumors , 2014, Molecular and Cellular Endocrinology.
[28] G. Åkerström,et al. The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors. , 2014, Endocrine-related cancer.
[29] J. Olson,et al. Functional and genetic studies of isolated cells from parathyroid tumors reveal the complex pathogenesis of parathyroid neoplasia , 2014, Proceedings of the National Academy of Sciences.
[30] A. Gill. Understanding the Genetic Basis of Parathyroid Carcinoma , 2014, Endocrine Pathology.
[31] N. Palanisamy,et al. Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins , 2013, Endocrine.
[32] F. Cetani,et al. The microRNA cluster C19MC is deregulated in parathyroid tumours. , 2012, Journal of molecular endocrinology.
[33] M. Nie,et al. Novel HRPT2/CDC73 Gene Mutations and Loss of Expression of Parafibromin in Chinese Patients with Clinically Sporadic Parathyroid Carcinomas , 2012, PloS one.
[34] G. Åkerström,et al. Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification. , 2012, The Journal of clinical endocrinology and metabolism.
[35] Howard Y. Chang,et al. Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.
[36] Paola Sebastiani,et al. Cluster analysis of gene expression dynamics , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] T. Dwight,et al. Alternative genetic pathways in parathyroid tumorigenesis. , 1999, The Journal of clinical endocrinology and metabolism.
[38] Y. Nakamura,et al. Allelotype of colorectal carcinomas. , 1989, Science.
[39] Jie Yang,et al. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer. , 2016, Cancer biomarkers : section A of Disease markers.
[40] Ming Sun,et al. Long Noncoding RNA PVT 1 Promotes Non – Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS 2 Expression , 2016 .
[41] J. Olson,et al. Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics. , 2010, The oncologist.
[42] U. Mansmann,et al. Genomic Profiling , 2005, Methods of Information in Medicine.